Kidney Tumor Cells

Kidney tumors represent a complex and heterogeneous group of malignancies, with Renal Cell Carcinoma (RCC) accounting for the vast majority of cases. These tumors are characterized by unique genetic drivers and metabolic alterations, making specialized cell line models indispensable for advancing our understanding of renal carcinogenesis and therapeutic response.

Our Kidney Tumor Cell collection provides a comprehensive array of in vitro models covering major histological subtypes, including clear cell, papillary, and chromophobe carcinomas. These tools enable researchers to explore the intricate signaling pathways involved in oxygen sensing, angiogenesis, and tumor-driven immune evasion.

Pathologically Diverse STR Authenticated Metabolically Characterized Research Ready

Product List

Key Features & Research Capabilities

Our renal oncology portfolio is designed to support a wide spectrum of basic and translational research:

Broad Histological Representation

Covers primary and metastatic models of Clear Cell Renal Cell Carcinoma (ccRCC).
Includes specialized models for Non-Clear Cell RCC and pediatric renal malignancies.
Provides cell lines derived from various metastatic sites to study organ-specific progression.

Molecular & Genetic Profiling

Characterized for critical renal cancer drivers, including VHL, PBRM1, and BAP1 status.
Optimized for investigating HIF-α signaling and VEGF-mediated angiogenesis.
Ideal for studying the "Warburg Effect" and lipid metabolism shifts unique to renal tumors.

Rigorous Quality Standards

Every cell line undergoes STR profiling to ensure identity and genetic stability.
Comprehensive screening for Mycoplasma and adventitious agents to ensure data integrity.
Proven performance in 2D cell-based assays and in vivo xenograft development.

FAQ

How do these models support targeted therapy research?

Our renal cell lines are extensively used to evaluate Tyrosine Kinase Inhibitors (TKIs) and mTOR inhibitors. They allow for the study of both intrinsic and acquired resistance mechanisms, helping to identify novel combination therapies.

Are these cell lines suitable for hypoxia and oxygen-sensing studies?

Yes. Given that the VHL-HIF axis is central to renal oncology, many of our models exhibit documented VHL deficiency, providing a stable platform for investigating hypoxia-inducible factors and their downstream targets.

Can I use kidney tumor cell lines for 3D culture or organoid-like assays?

Many of the lines in our collection demonstrate excellent self-assembly properties in 3D culture environments, which better mimic the tumor's spatial architecture and drug penetration profiles compared to traditional 2D monolayers.

Do you offer control cell lines for renal research?

To facilitate comparative studies, we provide normal human kidney epithelial cell lines. These serve as essential negative controls for identifying tumor-specific genetic alterations and evaluating drug toxicity.

What information is available regarding the metastatic potential of these lines?

We provide background data on the clinical origin of each line (e.g. , primary vs. metastatic). Lines derived from metastatic sites often exhibit enhanced migration and invasion capabilities in functional assays.

Filters Clear all filters